INSIGHTS ON CLINICAL TRIAL DESIGN

• Unlocking Recruitment Potential In Trial-Naïve Sites

  Site Professional Support enabled this late-phase rheumatoid arthritis study to conduct complex patient visits despite its use of sites that lacked research experience and resources.

• How High-Performing Trials Operationalize Health Equity Early

  Explore how embedding inclusion early in clinical development enhances enrollment, strengthens data integrity, and improves outcomes, especially in oncology and rare disease trials.

• Critical Imaging Risks In GLP-1 And Neurology Studies

  As imaging grows in importance within GLP-1 and neurology trials, it must be treated not as a routine task but as a strategic pillar that supports participant safety and reproducible outcomes.

• On-Demand Service Models Improve Clinical Trials

  As consumers increasingly expect convenience and immediacy, the on-demand model continues to reshape how services are delivered across nearly every sector.

• Streamlining Phase 1 Trials With The Mobile Vision Pod

  1/29/2025

  A contract research organization formed a partnership to address significant challenges during a Phase 1 clinical trial for a corneal disease treatment through the use of a Mobile Vision Pod.

• Retention Begins With Recruiting The Right-Fit Patients

  11/13/2025

  Recruiting the right patients into a clinical trial is only half the battle. To combat attrition, sponsors must also institute measures that ensure patients remain comfortable and confident throughout the trial.

• Obesity Clinical Research: Patient Recruitment Challenges

  1/15/2026

  Obesity trials face enrollment hurdles. Learn how data-driven insights, patient-first strategies, and decentralized models can break barriers, ease burden, and accelerate timelines.

• Advancing Immunotherapy In Head And Neck Cancer: The IT-MATTERS Study

  4/17/2025

  This randomized controlled pivotal Phase 3 study evaluated efficacy and safety of neoadjuvant complex biologic administered for three consecutive weeks pre-surgery.

• How Adaptive Design Accelerates Early‑Phase NSCLC Development

  5/22/2026

  Adaptive trial designs and an adaptive mindset enable non-small cell lung cancer (NSCLC) sponsors to optimize dose, respond to evolving expectations, and accelerate early‑phase development.